Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana
Abstract Background/Aim Immune tolerance in the fetal–maternal junction is maintained by a balance in the Th1/Th2 system. Th1‐type immunity is associated with pro‐inflammatory cytokines and immune checkpoint molecules (ICMs) such as B7‐H1, while Th2‐type immunity is characterized by anti‐inflammator...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.1142 |
| _version_ | 1827374717657415680 |
|---|---|
| author | Martin Awe Akilla Ignatius Abowini Awinibuno Nchor Moses Banyeh Nafiu Amidu |
| author_facet | Martin Awe Akilla Ignatius Abowini Awinibuno Nchor Moses Banyeh Nafiu Amidu |
| author_sort | Martin Awe Akilla |
| collection | DOAJ |
| description | Abstract Background/Aim Immune tolerance in the fetal–maternal junction is maintained by a balance in the Th1/Th2 system. Th1‐type immunity is associated with pro‐inflammatory cytokines and immune checkpoint molecules (ICMs) such as B7‐H1, while Th2‐type immunity is characterized by anti‐inflammatory cytokines and ICMs such as B7‐1. Any imbalance in the Th1/Th2 immune system may lead to adverse pregnancy outcomes such as pre‐eclampsia (PE). Hitherto, the potential of serum B7‐1 and B7‐H1 proteins as early markers of PE has not been explored in the Ghanaian population. Materials and Methods This was a case–control study from May 2020 to April 2022 at the War Memorial and the Upper East Regional Hospitals. The study involved 291 women, including 180 (61.9%) with normotensive pregnancy and 111 (38.1%) with PE. Venous blood samples were collected and assayed for blood cell count, serum interleukins (ILs)‐4, ‐6, ‐12, ‐18, and TNF‐α as well as serum B7‐1 and B7‐H1 proteins. Results The monocyte count (p = .007), the serum levels of IL‐18 (p = .035), TNF‐α (p = .001), and B7‐H1 (p = .006) were significantly higher in PE than in normotensive pregnancy. In addition, the monocyte count (p = .002), the serum levels of IL‐12 (p = .029), TNF‐α (p = .016), and B7‐1 (p = .009) levels were significantly higher in the third trimester than the second trimester PE. In predicting PE, the area under the curve of cytokines and ICMs ranged from 0.51 for IL‐6 to 0.62 for TNF‐α. Conclusion PE may be characterized by a dominant Th1‐type immunity with higher levels of pro‐inflammatory cytokines and B7‐H1 proteins, but these variables may not be suitable for predicting PE. |
| first_indexed | 2024-03-08T11:37:54Z |
| format | Article |
| id | doaj.art-01490a54b2fd4715b6b81063f357898a |
| institution | Directory Open Access Journal |
| issn | 2050-4527 |
| language | English |
| last_indexed | 2024-03-08T11:37:54Z |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Immunity, Inflammation and Disease |
| spelling | doaj.art-01490a54b2fd4715b6b81063f357898a2024-01-25T11:02:19ZengWileyImmunity, Inflammation and Disease2050-45272024-01-01121n/an/a10.1002/iid3.1142Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a GhanaMartin Awe Akilla0Ignatius Abowini Awinibuno Nchor1Moses Banyeh2Nafiu Amidu3Department of Biomedical Laboratory Science, School of Allied Health Sciences University for Development Studies Tamale GhanaDepartment of Biomedical Laboratory Science, School of Allied Health Sciences University for Development Studies Tamale GhanaDepartment of Biomedical Laboratory Science, School of Allied Health Sciences University for Development Studies Tamale GhanaDepartment of Biomedical Laboratory Science, School of Allied Health Sciences University for Development Studies Tamale GhanaAbstract Background/Aim Immune tolerance in the fetal–maternal junction is maintained by a balance in the Th1/Th2 system. Th1‐type immunity is associated with pro‐inflammatory cytokines and immune checkpoint molecules (ICMs) such as B7‐H1, while Th2‐type immunity is characterized by anti‐inflammatory cytokines and ICMs such as B7‐1. Any imbalance in the Th1/Th2 immune system may lead to adverse pregnancy outcomes such as pre‐eclampsia (PE). Hitherto, the potential of serum B7‐1 and B7‐H1 proteins as early markers of PE has not been explored in the Ghanaian population. Materials and Methods This was a case–control study from May 2020 to April 2022 at the War Memorial and the Upper East Regional Hospitals. The study involved 291 women, including 180 (61.9%) with normotensive pregnancy and 111 (38.1%) with PE. Venous blood samples were collected and assayed for blood cell count, serum interleukins (ILs)‐4, ‐6, ‐12, ‐18, and TNF‐α as well as serum B7‐1 and B7‐H1 proteins. Results The monocyte count (p = .007), the serum levels of IL‐18 (p = .035), TNF‐α (p = .001), and B7‐H1 (p = .006) were significantly higher in PE than in normotensive pregnancy. In addition, the monocyte count (p = .002), the serum levels of IL‐12 (p = .029), TNF‐α (p = .016), and B7‐1 (p = .009) levels were significantly higher in the third trimester than the second trimester PE. In predicting PE, the area under the curve of cytokines and ICMs ranged from 0.51 for IL‐6 to 0.62 for TNF‐α. Conclusion PE may be characterized by a dominant Th1‐type immunity with higher levels of pro‐inflammatory cytokines and B7‐H1 proteins, but these variables may not be suitable for predicting PE.https://doi.org/10.1002/iid3.1142cytokinesGhanaimmune checkpoint proteinspre‐eclampsiapregnancy |
| spellingShingle | Martin Awe Akilla Ignatius Abowini Awinibuno Nchor Moses Banyeh Nafiu Amidu Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana Immunity, Inflammation and Disease cytokines Ghana immune checkpoint proteins pre‐eclampsia pregnancy |
| title | Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana |
| title_full | Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana |
| title_fullStr | Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana |
| title_full_unstemmed | Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana |
| title_short | Immune checkpoint molecules B7‐1 and B7‐H1 as predictive markers of pre‐eclampsia: A case–control study in a Ghana |
| title_sort | immune checkpoint molecules b7 1 and b7 h1 as predictive markers of pre eclampsia a case control study in a ghana |
| topic | cytokines Ghana immune checkpoint proteins pre‐eclampsia pregnancy |
| url | https://doi.org/10.1002/iid3.1142 |
| work_keys_str_mv | AT martinaweakilla immunecheckpointmoleculesb71andb7h1aspredictivemarkersofpreeclampsiaacasecontrolstudyinaghana AT ignatiusabowiniawinibunonchor immunecheckpointmoleculesb71andb7h1aspredictivemarkersofpreeclampsiaacasecontrolstudyinaghana AT mosesbanyeh immunecheckpointmoleculesb71andb7h1aspredictivemarkersofpreeclampsiaacasecontrolstudyinaghana AT nafiuamidu immunecheckpointmoleculesb71andb7h1aspredictivemarkersofpreeclampsiaacasecontrolstudyinaghana |